Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Smith

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Rheumatology (Oxford, England)|December 9, 2025
Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitisKatya Meridor, Sook Yan Lee, Ilona Blee, et al.
Haematologica|January 26, 2023
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemiaHolly Pariury, Joshua Fandel, Stefanie Bachl, et al.
JCO Clinical Cancer Informatics|June 20, 2025
Patient Perspectives on Technological Barriers and Implementation Strategies Leveraged During a Real-World Remote Symptom Monitoring ProgramTanvi V Padalkar, Nicole L Henderson, D'Ambra N Dent, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2016
Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazineDmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2016
Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazineDmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
Science (New York, N.Y.)|September 28, 2005
Transmission of equine influenza virus to dogsP C Crawford, Edward J Dubovi, William L Castleman, et al.
Experimental Dermatology|August 13, 2021
The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseasesHarri Alenius, Hanna Sinkko, Lucas Moitinho-Silva, et al.
BMJ (Clinical Research Ed.)|October 28, 2024
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guidelineLeticia Kawano-Dourado, Eirik Klami Kristianslund, Dena Zeraatkar, et al.
The Journal of Infectious Diseases|January 24, 2018
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United StatesBrendan Flannery, Catherine Smith, Rebecca J Garten, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Rheumatology (Oxford, England)|December 9, 2025
Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitisKatya Meridor, Sook Yan Lee, Ilona Blee, et al.
Haematologica|January 26, 2023
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemiaHolly Pariury, Joshua Fandel, Stefanie Bachl, et al.
JCO Clinical Cancer Informatics|June 20, 2025
Patient Perspectives on Technological Barriers and Implementation Strategies Leveraged During a Real-World Remote Symptom Monitoring ProgramTanvi V Padalkar, Nicole L Henderson, D'Ambra N Dent, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2016
Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazineDmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2016
Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazineDmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
Science (New York, N.Y.)|September 28, 2005
Transmission of equine influenza virus to dogsP C Crawford, Edward J Dubovi, William L Castleman, et al.
Experimental Dermatology|August 13, 2021
The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseasesHarri Alenius, Hanna Sinkko, Lucas Moitinho-Silva, et al.
BMJ (Clinical Research Ed.)|October 28, 2024
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guidelineLeticia Kawano-Dourado, Eirik Klami Kristianslund, Dena Zeraatkar, et al.
The Journal of Infectious Diseases|January 24, 2018
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United StatesBrendan Flannery, Catherine Smith, Rebecca J Garten, et al.
Pageof 19